LONG-TERM OUTCOMES OF RETINAL DEGENERATIVE DISORDER TREATMENT WITH PEPTIDE BIOREGULATORS

Aim. To analyze long-term outcomes and efficacy of retinal degeneration treatment with Retinalamin.

Patients and methods. Group I included 20 patients (40 eyes) with pigmentary retinal dystrophy (15 patients, 30 eyes) and retinal abiotrophy (5 patients, 10 eyes) who received treatment with Retinalamin for 5‑7 years. Group II included 11 patients (22 eyes) with pigmentary retinal dystrophy (9 patients, 18 eyes) and retinal abiotrophy (2 patients, 4 eyes) who received treatment with Retinalamin for 23‑25 years. Group III (controls) included 15 patients (30 eyes) with pigmentary retinal dystrophy (11 patients, 22 eyes) and retinal abiotrophy (4 patients, 8 eyes) who received traditional treatment (vasodilators, angioprotectors, antisclerotic agents, vitamins) for 25 years. Standard ophthalmological examination, i.e., visual acuity measurement, visual field test, refractometry, biomicroscopy, ophthalmoscopy, was performed.

Results. First course of treatment with Retinalamin improved vision in 58.1 % of retinal degeneration patients. Visual fields improved in 64.5 % of cases. Repeated treatment courses (1‑2 times a year) for 23‑25 years preserved residual vision in 55.6 % of patients and object vision in 11.1 % of cases. In retinal abiotrophy patients, residual vision preserved in 100 % of cases.

Conclusions. In retinal degenerations, Retinalamin improves vision and visual fields and decreases total area of absolute scotomas even after the first treatment course as well as preserves vision in prolonged use.

1. Alekseev V. N., Medvednikova T. N., Litvin I. B. [Retinalamin and Cortexin use in the treatment of pigmentary peripheral retinal abyotrophy]. Primenenie retinalamina i korteksina v lechenii pigmentnoy perifericheskoy abiotrofii setchatki. In: Maksimov I. B., Neroev V. V. [Retinalamin. Neuroprotection in ophthalmology]. Retinalamin. Neyroprotektsiya v oftal’mologii. St. Petersburg, Nauka, 2007: 89‑97. (in Russ.).

2. Maksimov I. B., Neroev V. V., Alekseev V. N., Razumovskiy M. I., Trofimova S. V. [Retinalamin use in ophthalmology. Guidelines for doctors]. Primenenie preparata retinalamin v oftal’mologii. Posobie dlya vrachey. St. Petersburg, IKF Foliant, 2006. (in Russ.).

3. Khavinson V. Kh., Neroev V. V., Trofimova S. V., Osokina Yu. Yu. [Unique technology of the restoration of damaged retina functions in various disorders]. Unikal’naya tekhnologiya vosstanovleniya funktsii porazhennoy setchatki glaza pri razlichnykh zabolevaniyakh. St. Petersburg, Institut bioregulyatsii i gerontologii, 2011. (in Russ.).

4. Neroev V. V., Khvatova A. V., Khlebnikova O. V. [Efficacy of retinalamin in retinal abyotrophy in children]. Effektivnost’ primeneniya retinalamina pri abiotrofii setchatki u detey. In: Maksimov I. B., Neroev V. V. [Retinalamin. Neuroprotection in ophthalmology]. Retinalamin. Neyroprotektsiya v oftal’mologii. St. Petersburg, Nauka, 2007: 119‑128. (in Russ.).

5. Rasumovskij M., Grigorian A., Rasumovskaja A. Neuropeptide retiline as a protector of retinal dystrophy in Campbell rats: Neuroscience Annual Meeting. 1994, Nov. 13‑18; Miami Beach; USA: 17-18.

6. Rasumovskij M.,V. Khavinson, Rasumovskaja A. Study of the retina-protective effect of epitalon in Campbell rats: First meeting on research in vision and ophthalmology. 2003, Feb. 6‑9; Singapore: 118.

7. Nalobnova Yu. V., Egorov E. A, Stavitskaya T. V., Asrorova G. K. [Cytomedines use in ophthalmology]. Primenenie tsitomedinov v oftal’mologii. [Clinical Ophthalmology]. Klinicheskaya oftal’mologiya. 2003; 11 (4): 176‑178. (in Russ.).

8. Khasanova N. Kh., Belyaeva A. V. [The results of Retinalamin use in retinal disorders]. Rezul’taty primeneniya Retinalamina pri zabolevaniyakh setchatki. [Clinical Ophthalmology]. Klinicheskaya oftal’mologiya. 2008; 16 (3): 77-81. (in Russ.).

9. Khavinson V. Kh., Trofimova S. V., Osokina Yu. Yu., Gorbunov A. V. [Current aspects of age-related macular degeneration therapy in elderly and senile patients]. Sovremennye aspekty terapii vozrastnoy makulyarnoy distrofii u lits pozhilogo i starcheskogo vozrasta. [Scientific Bulletin of Belgorod State University]. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. 2011; 16 (15 / 1): 57‑62. (in Russ.).

10. Studenikin V. M., Pak L. A., Balkanskaya S. V., Shelkovskiy V. I., Tursunkhodzhaeva S. Sh. [Peptide bioregulators and their use: from neonatology to gerontology]. Peptidnye bioregulyatory i ikh primenenie: ot neonatologii do gerontologii. [Attending Doctor]. Lechashchiy vrach. 2010; 6: 72‑75. (in Russ.).

11. Nepomnyashchikh V. A. [Cellular bioregulators in the complex treatment of ocular diseases: monograph-guidelines]. Kletochnye bioregulyatory v kompleksnoy terapii glaznykh bolezney: monografiya-rukovodstvo. Moscow, RegBioMed, 2010. (in Russ.).

12. Kharintseva S. V. [Retinal protection therapy of diabetic macular edema in elderly persons]. Retinoprotektornaya terapiya diabeticheskogo makulyarnogo oteka u pozhilykh lyudey. [Advances in gerontology]. Uspekhi gerontologii. 2011; 24 (3): 521-523. (in Russ.).

13. Khavinson V. Kh., Kuznik B. I., Ryzhak G. A. [Peptide bioregulators, a novel class of gerontology protectors. Report No. 1. Results of clinical studies]. Peptidnye bioregulyatory — novyy klass geroprotektorov. Soobshchenie 1. Rezul’taty klinicheskikh issledovaniy. [Advances in gerontology]. Uspekhi gerontologii. 2012; 25 (4): 696-708. (in Russ.).

14. Khavinson V. Kh., Kuznik B. I., Ryzhak G. A. [Peptide bioregulators, a novel class of gerontology protectors. Report No. 2. Results of clinical studies]. Peptidnye bioregulyatory — novyy klass geroprotektorov. Soobshchenie 1. Rezul’taty klinicheskikh issledovaniy. [Advances in gerontology]. Uspekhi gerontologii. 2013; 26 (1): 20‑37. (in Russ.).

15. Chudinova O. V., Khokkanen V. M. [Retinalamin, peptide regulator, in the treatment of chronic uveitis]. Peptidnyy regulyator retinalamin v lechenii khronicheskikh uveitov. [Refractive Surgery & Ophthalmology]. Refraktsionnaya khirurgiya i oftal’mologiya. 2009; 9 (4): 45-48. (in Russ.).

16. Khavinson V. Kh., Anisimov V. N. [Peptide regulation of ageing: 35 years of experience]. Peptidnaya regulyatsiya stareniya: 35-letniy opyt issledovaniy. [Bulletin of Experimental Biology & Medicine]. Byulleten’ eksperimental’noy biologii i meditsiny. 2009; 148 (7): 108-113. (in Russ.).

17. Trofimova C. B., Gorbunov A. B., Pronyaeva B. E. [The role of melatonin in the development of retinal disorders in senile patients]. Rol’ melatonina v razvitii patologii setchatki u patsientov starshey vozrastnoy gruppy. [Advances in gerontology]. Uspekhi gerontologii. 2012; 25 (2): 239-243. (in Russ.).